Interleukin-10 stimulation of corticotrophin releasing factor median eminence in rats: Evidence for dependence upon nitric oxide production

Neuroscience Letters

Volumn 256, Issue 3, 1998, Pages 167-170

  Stefano, George B ^a   Prevot, Vincent ^b   Beauvillain, Jean Claude ^b   Hughes, Thomas K ^c  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b INSERM   (France)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Hypothalamus; Interleukin 10; Median eminence; Neuroimmunoiogy; Nitric oxide

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; INTERLEUKIN 10; MESSENGER RNA; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HORMONAL REGULATION; HORMONE RELEASE; MALE; MEDIAN EMINENCE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ANALYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, SOUTHERN; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERLEUKIN-10; LEUKOCYTES; MALE; MEDIAN EMINENCE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PITUITARY GLAND; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0032515093     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00703-4     Document Type: Article

References (23)

1. Blalock J.E., Smith E.M. A complete regulatory loop between the immune and neuroendocrine systems. Fed. Proc. 44:1985;101-111.
2. Costa A., Trainer P., Besser M., Grossman A. Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res. 2:1993;187-192.
3. Cunha F.Q., Moncada S., Liew F.Y. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem. Biophys. Res. Commun. 182:1992;1155-1159.
4. Hughes T.K., Cadet P., Rady P., Tyring S.K., Smith E.M. Evidence for production and action of interleukin 10 in the pituitary. Cell. Mol. Neurobiol. 14:1994;57-67.
5. Hughes, T.K. and Chin, R., Interactions of neuropeptide and lymphokines. In B. Scharrer, G.B. Stefano and E.M. Smith (Eds.), Neuropeptides and Immunoregulation, Springer, Berlin, 1994, pp. 101-119.
6. Hughes T.K., Smith E.M. Corticotropin (ACTH) induces tumor necrosis factor-alpha production. J. Biol. Reg. Homeost. Agents. 3:1989;163-166.
7. Johnson H.M., Smith E.M., Torres B.A., Blalock J.E. Neuroendocrine hormone regulation of in vitro antibody production. Proc. Natl. Acad. Sci. USA. 79:1982;4171-4174.
8. Johnson H.M., Smith E.M., Torres B.A., Blalock J.E. Regulation of lymphokine (gamma interferon) production by corticotropin. J. Immunol. 132:1984;246-250.
9. Karanth S., Lyson K., McCann S. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc. Natl. Acad. Sci. USA. 90:1993;3383-3387.
10. Makman M.H., Blifinger T.V., Stefano G.B. Human granulocytes contain an opiate receptor mediating inhibition of cytokine-induced activation and chemotaxis. J. Immunol. 154:1995;1323-1330.
11. Moore K.W., O'Garra A., de Waal Malefyt R., Viera P., Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11:1993;165-190.
12. Opp M.R., Rady P.L., Hughes T.K., Cadet P., Tyring S.K., Smith E.M. Human immunodeficiency virus envelope glycoprotein 120 alters sleep and induces cytokine mRNA expression in rats. Am. J. Physiol. 270:1996;963-970.
13. Opp M.R., Smith E.M., Hughes T.K. Interleukin 10 acts in the central nervous system of rats to reduce sleep. J. Neuroimmunol. 60:1995;165-168.
14. Oswald I.P., Gazzinelli R.T., Sher A., James S.L. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J. Immunol. 148:1992;3578-3782.
15. Prevot V., Ralias C.M., Croix D., Salzet M., Dupuoy J.P., Poulain P., Beauvillain J.C., Stefano G.B. Evidence for nitric oxide (NO) production by median eminence via endothelial 3 and cannabinoid receptors activation. Implication in release of GnRH and CRF. Brain Res. 790:1998;236-244.
16. Raber J., Koob G.F., Bloom F.E. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling: comparison with the hypothalamic response. J. Pharmacol. Exp. Ther. 272:1995;815-824.
17. Rady P., Smith E.M., Cadet P., Opp M.R., Tyring S.K., Hughes T.K. Presence of IL-10 transcripts in human pituitary and hypothalamus. Cell. Mol. Neurobiol. 15:1995;279-286.
18. Stefano G.B., Christensen V.B., Tonnesen E., Liu Y., Hughes T.K., Bilfinger T.V. Interleukin 10 stimulation of endogenous nitric oxide release from human saphenous veins diminishes immunocyte adherence. J. Cardiovasc. Pharmacol. 30:1997;90-95.
19. 3 opiate receptor in endothelial cells. J. Biol. Chem. 270:1995;30290-30293.
20. Stefano G.B., Liu Y., Goligorsky M.S. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia and human monocytes. J. Biol. Chem. 271:1996;1-5.
21. Stefano, G.B., Salzet, M., Magazine, H.I. and Bilfinger, T.V., Antagonist of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase, J. Cardiovasc. Pharmacol., (1998) in press.
22. Stefano G.B., Scharrer B., Smith E.M., Hughes T.K., Magazine H.I., Bilfinger T.V., Hartman A.R., Fricchione B.L., Liu Y., Makman M. Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 16:1996;109-144.
23. Vieira P., de Waal-Malefyt R., Dang M.N., Johnson K.E., Kastelein R., Fiorentino D.F., De Vries J.E., Roncarolo M.G., Mosmann T.R., Moore K.W. Isolation and expression of cytokine synthesis inhibitory factor cDNA clones. Homology to Epstein-Barr virus open reading frame BCRF1. Proc. Natl. Acad. Sci. USA. 88:1991;1172-1176.